Serial Number
97696615
Owner
Element Biosciences, Inc.Attorney
Samantha C. MarkleyFiling Date
Nov 29, 2022
LOOPSEQ Trademark
Serial Number: 97696615
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
9880 Campus Point Drive, Suite 210
San Diego, CA 92121
Entity Type: 03
Legal Representation
Correspondence Address
Samantha C. Markley LOZA & LOZA, LLP
305 N. SECOND AVE., #127
UPLAND, CA 91786
United States
Trademark Details
Filing Date
November 29, 2022
Registration Date
Not Registered
Published for Opposition
December 12, 2023
Goods & Services
Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes
Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes
DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data
DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes
